These included four stage I cancer samples (two pre- and two post-menopausal) with CA125 < 35 U/mL which were not identified by CA125 or ROMA index; whilst one additional sample (post-menopausal, CA125 = 9 U/mL) was correctly identified by the multi-marker panel. This evidence concerns the gene MUC16 and cancer.